1. Home
  2. INNV vs NVAX Comparison

INNV vs NVAX Comparison

Compare INNV & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$10.75

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.33

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INNV
NVAX
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
INNV
NVAX
Price
$10.75
$9.33
Analyst Decision
Sell
Hold
Analyst Count
1
9
Target Price
$7.00
$11.33
AVG Volume (30 Days)
219.3K
5.4M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
309.76
EPS
N/A
N/A
Revenue
$989,707,000.00
$1,123,479,000.00
Revenue This Year
$12.85
N/A
Revenue Next Year
$8.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.93
64.69
52 Week Low
$3.94
$6.20
52 Week High
$12.64
$11.85

Technical Indicators

Market Signals
Indicator
INNV
NVAX
Relative Strength Index (RSI) 48.70 56.71
Support Level $7.33 $8.42
Resistance Level $11.97 $10.10
Average True Range (ATR) 0.52 0.61
MACD -0.01 -0.03
Stochastic Oscillator 27.41 37.64

Price Performance

Historical Comparison
INNV
NVAX

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: